Nanocarry
Manufacturing · Illinois, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3 Pinchas Sapir, Illinois, United StatesWebsite
www.nanocarry.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nanocarry
Nanocarry is focused on developing first-in-class therapeutics aimed at treating brain cancers and central nervous system (CNS) diseases. The company utilizes a proprietary technology platform that enables biologics to overcome the Blood-Brain Barrier, thereby enhancing the delivery of therapeutics to the brain. Their current pipeline includes neuro-oncology treatments for brain metastases and seeks partnerships for developing next-generation therapeutics for neurodegenerative and genetic CNS diseases. Nanocarry's innovative approach aims to revolutionize the treatment landscape for patients suffering from neurological conditions.Explore more
Nanocarry Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nanocarry your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Nanocarry has new funding data
Earning: See what the market has to say on Nanocarry recently announced quarterly report
Click to see if Nanocarry had a recent Job posting/layoffs
Check out if Nanocarry is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Nanocarry
Product Launch: Get notified when Nanocarry launches new products
Website visits: Recent activity has been detected on your website
Nanocarry, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Nanocarry has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Nanocarry
Find more new buyers
Compare Similar Companies to Nanocarry
Compare insights from companies similar to Nanocarry, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nanocarry is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nanocarry is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nanocarry.
Nanocarry Tech Stack
A closer look at the technologies used by Nanocarry
See more technologies
Nanocarry News & Media
Genuv Teams With Nanocarry Therapeutics to Develop Novel anti-PD-1 mAb Treatments That Can Cross the Blood-Brain Barrier
SEOUL, South Korea & NESS ZIONA, Israel--(BUSINESS WIRE)-- #ASCO2022--Genuv Inc., a clinical-stage biotechnology company focused on innovative drug discovery for central nervous system disorders and advanced antibody therapies, and Nanocarry Therapeutics, a private company developing a new class of therapeutics capable of crossing the Blood-Brain Barrier (BBB), announced an agreement to collaborate on the development of an experimental drug to treat metastatic lung cancer. Specifically, this col
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nanocarry
Sign Up For FreeTo access detailed company insights
Nanocarry is focused on developing first-in-class therapeutics aimed at treating brain cancers and central nervous system (CNS) diseases. The company utilizes a proprietary technology platform that enables biologics to overcome the Blood-Brain Barrier, thereby enhancing the delivery of therapeutics to the brain. Their current pipeline includes neur... Read More
